Date published: 2025-9-7

021-6093-6350

SCBT Portrait Logo
Seach Input

PTPκ 抑制因子

PTPκ Inhibitors are a class of chemical compounds that target and inhibit the activity of protein tyrosine phosphatase kappa (PTPκ), an enzyme belonging to the protein tyrosine phosphatase (PTP) family. PTPκ is a transmembrane receptor-type phosphatase that plays a critical role in cellular signaling pathways by dephosphorylating specific tyrosine residues on target proteins. This dephosphorylation process is essential for regulating various cellular functions, including cell adhesion, migration, and signaling cascades involved in cell growth and differentiation. PTPκ is particularly noted for its involvement in the regulation of cadherin-mediated cell-cell adhesion, a fundamental process in maintaining tissue architecture and integrity.

The use of PTPκ Inhibitors in research allows scientists to investigate the complex signaling networks that PTPκ influences, particularly those related to cell-cell communication and the maintenance of epithelial cell integrity. By inhibiting PTPκ activity, researchers can explore the downstream effects on cadherin-mediated adhesion and how disruptions in this process can affect cellular behavior. These inhibitors are valuable tools for studying the dynamics of cell adhesion molecules and their role in tissue morphogenesis, wound healing, and cellular response to environmental changes. Additionally, PTPκ Inhibitors provide insights into the broader regulatory mechanisms of tyrosine phosphorylation and dephosphorylation in cellular signaling networks, offering a deeper understanding of how cells coordinate their functions and maintain homeostasis. Overall, PTPκ Inhibitors are critical for advancing knowledge in cell biology, particularly in areas related to cell adhesion, signaling, and the intricate balance of phosphorylation states that govern cellular processes.

関連項目

Items 1 to 10 of 16 total

展示:

产品名称CAS #产品编号数量价格应用排名

Imatinib

152459-95-5sc-267106
sc-267106A
sc-267106B
10 mg
100 mg
1 g
¥282.00
¥1320.00
¥2358.00
27
(1)

通过结合PTPR的活性位点来抑制其活性,从而阻止其酶促活性。

Dasatinib

302962-49-8sc-358114
sc-358114A
25 mg
1 g
¥530.00
¥1636.00
51
(1)

阻断PTPR的磷酸化与活化,降低其信号传导功能。

Nilotinib

641571-10-0sc-202245
sc-202245A
10 mg
25 mg
¥2313.00
¥4569.00
9
(1)

通过结合PTPR的激酶结构域来抑制其活性,从而阻止其自身磷酸化。

AP 24534

943319-70-8sc-362710
sc-362710A
10 mg
50 mg
¥1941.00
¥10876.00
2
(1)

靶向PTPR和其他激酶,抑制其活化和下游信号传导。

Sunitinib, Free Base

557795-19-4sc-396319
sc-396319A
500 mg
5 g
¥1692.00
¥10379.00
5
(0)

通过抑制PTPR的磷酸化与活化来干扰其信号传导。

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
¥632.00
¥2933.00
¥4693.00
129
(3)

通过抑制其激酶结构域来破坏PTPR介导的信号级联。

Regorafenib

755037-03-7sc-477163
sc-477163A
25 mg
50 mg
¥3610.00
¥4851.00
3
(0)

通过阻断其激酶结构域来抑制PTPR活性,从而阻碍下游效应。

Ibrutinib

936563-96-1sc-483194
10 mg
¥1726.00
5
(0)

靶向PTPR和其他激酶,削弱其信号传导功能。

Acalabrutinib

1420477-60-6sc-507392
250 mg
¥2877.00
(0)

通过与PTPR激酶结构域结合并阻止其活化来抑制PTPR信号传导。

Sodium Orthovanadate

13721-39-6sc-3540
sc-3540B
sc-3540A
5 g
10 g
50 g
¥508.00
¥632.00
¥2065.00
142
(4)

一种已知的非特异性蛋白酪氨酸磷酸酶抑制剂,可通过模拟酶底物的过渡状态来抑制PTPR活性。